Price et al., 2013)
20213BCJL22049), National Key R&D Program of China (2024YFA1307103), and Jiangxi Province Key Laboratory of Bioengineering Drugs (No
Feb 6, 2026 After 48 weeks, one patient lost 20.1% of their body weight
Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hfner M, Schmiegel WH: Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers
For patients, the practical takeaway is straightforward: if your inflammation is closely tied to insulin resistance, central weight gain, fatty liver, or metabolic syndrome, a GLP-1 medication may help